Individual privacy. Organisational insight.
Nexynaptics is designed around a clear separation between participant-level information and organisational reporting.
Individual assessment information should remain with the participant and authorised care pathway, subject to informed consent and applicable privacy requirements.
Organisational reporting is designed to use appropriate aggregated and de-identified information, subject to participant consent, program design and applicable privacy requirements.
Individual health information should not routinely be disclosed to employers.
Participation is voluntary with explicit participant informed consent.